V020-1792 Screening compound: 4-[4-(4-methylphenoxy)-6-(4-nitrobenzoyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

V020-1792 Screening compound: 4-[4-(4-methylphenoxy)-6-(4-nitrobenzoyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine
V020-1792 Screening compound: 4-[4-(4-methylphenoxy)-6-(4-nitrobenzoyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-1792
4-[4-(4-methylphenoxy)-6-(4-nitrobenzoyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-1792

Molecular Formula

C25H25N5O5 (C25 H25 N5 O5)

Compound Name

4-[4-(4-methylphenoxy)-6-(4-nitrobenzoyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

IUPAC name

4-[4-(4-methylphenoxy)-6-(4-nitrobenzoyl)-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]morpholine

SMILES

Cc(cc1)ccc1Oc1c(CN(CC2)C(c(cc3)ccc3[N+]([O-])=O)=O)c2nc(N2CCOCC2)n1

InChI

InChI=1S/C25H25N5O5/c1-17-2-8-20(9-3-17)35-23-21-16-29(24(31)18-4-6-19(7-5-18)30(32)33)11-10-22(21)26-25(27-23)28-12-14-34-15-13-28/h2-9H,10-16H2,1H3

InChI Key

RXIQCKMXHHADOP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19908226

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

475.5

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.125

Distribution Coefficient, logD

4.125

Water Solubility, LogSw

-4.16

Polar Surface Area

87.795

Acid Dissociation Constant (pKa)

20.15

Base Dissociation Constant (pKb)

1.77

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

V020-1792 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V020-1792 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-1792?
Check Price and Availability of V020-1792, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-1792 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-1792
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-1792
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-1792 available by request